ClinicalTrials.Veeva

Menu

One-year Cardiac Follow-up of Patients With COVID-19 Pneumonia

T

Tomsk National Research Medical Center of the Russian Academy of Sciences

Status

Completed

Conditions

Cardiac Complication
Covid19

Treatments

Diagnostic Test: Evaluation of clinical, instrumental and laboratory diagnostics tests

Study type

Observational

Funder types

Other

Identifiers

NCT04501822
TCRC-COVID

Details and patient eligibility

About

The primary objective of the study is to assess the cardiac status of COVID-19 pneumonia patients during 1 year after discharge

Full description

Although COVID-19 manifests in most cases with respiratory symptoms, cardiovascular abnormalities is common in hospitalized patients. Patients with cardiovascular risk factors or established disease appear to have a worse prognosis. Myocardial dysfunction could be a direct manifestation of COVID-19. The investigators hypothesize that subjects after COVID-19 pneumonia present myocardial and vascular remodeling during 1 year after discharge, even in the absence of prior cardiovascular disease.

Enrollment

380 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

-Patients with documented COVID-19 pneumonia

Exclusion criteria

  • Patients with cancer
  • Impossible to follow up

Trial design

380 participants in 1 patient group

Covid19 pneumonia patients
Description:
The study includes men and women ≥18 years old with documented COVID-19 pneumonia
Treatment:
Diagnostic Test: Evaluation of clinical, instrumental and laboratory diagnostics tests

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems